Back to Trials
NCT00900471Recruiting

Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors

Wake Forest University Health Sciences

Start Date

4/1/2004

Completion Date

5/1/2027

Summary

RATIONALE: Collecting and storing samples of tissue or blood from patients with cancer for study in the laboratory may help the study of cancer in the future PURPOSE: This research study is collecting and storing blood and tissue samples from patients with suspected solid tumors.

Detailed Description

OBJECTIVES: * To provide a tissue and cell repository to be used by Wake Forest University Comprehensive Cancer Center (WFUCCC) investigators. * To provide specialized research pathology services to these investigators. OUTLINE: Tumor and normal tissue in the resected specimen (when possible) are harvested and collected from patients undergoing planned surgery or biopsy. Additionally, any normal tissue and/or fluid removed in the course of the operation (e.g., cerebrospinal fluid during brain tumor resection) may also be stored for use in analyzing changes from normal tissue to cancerous tissue. Specimens are rapidly frozen in liquid nitrogen to preserve the mRNA, proteins, lipids, and DNA in the samples for future analysis. Tissue is stored for research projects on tumors and treatment of cancer patients. Research may involve analysis of the genetic makeup of the tumor tissue. Genes may be cloned and living cells cultured from the stored tissue. Blood is also collected during surgery. Samples are maintained and cataloged for future retrieval. Information about medical history is collected from patient medical records. This information includes the following: medical diagnosis; specific information about treatment; other medical conditions; medical data (i.e., laboratory test results, tumor measurements, CT scans, MRI scans, x-rays, and pathology results); side effects experienced and treatment for side effects; long-term information about general health status and the status of disease; data that may be related to tissue and/or blood samples collected; and identifying numbers or codes (i.e., social security number and medical record number).

Eligibility Criteria

Age Range: 18 years to 120 years

Inclusion Criteria: * Signed protocol specific informed consent prior to registration/randomization. * Clinically suspected solid tumor AND scheduled for surgical resection and/or biopsy

Interventions

OTHER

biologic sample preservation procedure

OTHER

medical chart review

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Unspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific

Locations

Wake Forest University Comprehensive Cancer Center

Winston-Salem, North Carolina 27157-1096

United States